Sandoz sees attractive opportunities in Japan on steady generic growth
This article was originally published in Scrip
Executive Summary
Helped by improving growth in the wider generics sector, Sandoz is seeing a solid expansion of its sales in Japan, which it views as one of its "most attractive and significant" business opportunities over the mid-term.